Result of GM, Issue of Equity
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your VAL notes
Director and PDMR Shareholding
ValiRx plc (the "Company") (AIM: VAL), announces that, further to the Conditional Fundraise & Notice of General Meeting announcement dated 13 December 2023, at its General Meeting held earlier today, resolutions 1 and 3 were duly passed and resolution 2 was not passed. Details of the votes received in respect of the resolutions will be available shortly on the Company's website.
Director and PDMR Shareholdings
Following completion of the Fundraising, the shareholdings of the Directors and PDMRs who participated in the Fundraising are set out in the table below:
| Director/PDMR | Existing beneficial shareholding | Fundraising Shares subscribed for | Beneficial shareholding on completion of the Fundraising | Beneficial shareholding as a percentage of the Enlarged Share Capital |
|---|---|---|---|---|
| Suzanne Dilly | 416,668 | 66,666 | 483,334 | 0.37% |
| Kevin Cox | 372,333 | 150,000 | 522,333 | 0.39% |
| Gerry Desler | 128,668 | 66,666 | 195,334 | 0.15% |
| Martin Lampshire | 144,000 | 150,000 | 294,000 | 0.22% |
| Stella Panu | - | 333,333 | 333,333 | 0.25% |
| Cathy Tralau-Stewart | - | 66,666 | 66,666 | 0.05% |
Issue of Equity
The Placing Shares, the Subscription Shares and the Retail Offer Shares have been allotted, conditional upon Admission, and application has been made to the London Stock Exchange for, in aggregate, 30,029,063 Placing Shares, Subscription Shares and Retail Offer Shares to be admitted to trading on AIM. Admission is expected to occur at 8.00 a.m. on 8 January 2024, with dealings in the Placing Shares, the Subscription Shares and the Retail Offer Shares commencing at the same time. The Placing Shares, the Subscription Shares and the Retail Offer Shares will rank pari passu with all other issued Shares.
The Fundraising remains conditional, inter alia, upon Admission and the Placing Agreement not being terminated in accordance with its terms.
Total Voting Rights
For the purpose of the Disclosure Guidance and Transparency Rules, following Admission the enlarged issued share capital of the Company will comprise 132,348,673 ordinary shares of 0.1 pence each. The Company does not hold any shares in the treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure Guidance and Transparency Rules.
Capitalised terms used in this announcement have the meaning given to them in the Conditional Fundraise, Notice of General Meeting announcement dated 13 December 2023, unless otherwise defined in this announcement.
The Directors of the Company take responsibility for this announcement.
| a. | Name | a) Suzanne Dilly b) Kevin Cox c) Gerry Desler d) Martin Lampshire e) Stella Panu f) Cathy Tralau-Stewart |
| 2 | Reason for notification | |
| a. | Position/Status | a) Director b) Director c) Director d) Director e) Director f) PDMR |
| b. | Initial notification/ Amendment | Initial notification |
| a. | Name | ValiRx PLC |
| b. | LEI | 213800VQKB9SJCQDET40 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary Shares ISIN: GB00BLH13C52 |
| b. | Nature of the transaction | Purchase of shares as part of the Fundraising |
| c. | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| a) 6p b) 6p c) 6p d) 6p e) 6p f) 6p | a) 66,666 b) 150,000 c) 66,666 d) 150,000 e) 333,333 f) 66,666 | |
| d. | Aggregated information - Aggregated Volume - Price | N/A |
| f. | Place of the transaction | Outside a trading venue |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.